Bactericidal agent composition
US-9220799-B2 · Dec 29, 2015 · US
US9750243B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9750243-B2 |
| Application number | US-201514616407-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2015 |
| Priority date | Feb 6, 2015 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An aqueous adjuvant concentrate can be prepared using a formulation including: a. from about 15 to about 45% by weight of a potassium salt chosen among di-potassium phosphate, potassium sulfate, potassium nitrate, tri-potassium citrate, potassium salts of ethylenediaminetetraacetic acid and mixture thereof; b. from about 0.5 to about 6% by weight of at least one surfactant and c. from about 3 to about 9% by weight of a hydroxypropyl tamarind gum; wherein a, b, and c are dissolved into the aqueous adjuvant. The aqueous adjuvant can include other compounds such as ah herbicide.
Opening claim text (preview).
What is claimed is: 1. An aqueous adjuvant concentrate comprising: a. from about 15 to about 45% by weight of a potassium salt chosen among di-potassium phosphate, potassium sulfate, potassium nitrate, tri-potassium citrate, potassium salts of ethylenediaminetetraacetic acid and mixture thereof; b. from about 0.5 to about 6% by weight of at least one surfactant and c. from about 3 to about 9% by weight of a hydroxypropyl tamarind gum; wherein a, b, and c are dissolved into the aqueous adjuvant. 2. The aqueous adjuvant concentrate of claim 1 wherein: a. is from about 20 to about 35% by weight of a potassium salt chosen among di-potassium phosphate, potassium sulfate, potassium nitrate, tri-potassium citrate, potassium salts of ethylenediaminetetraacetic acid, and mixture thereof; b. from about 1 to about 4% by weight of at least a surfactant and c. from about 3 to about 8% by weight of a tamarind gum. 3. The aqueous adjuvant concentrate of claim 1 wherein the potassium salt is a mixture of di-potassium phosphate, potassium nitrate and tri-potassium citrate. 4. The aqueous adjuvant concentrate of claim 1 wherein the surfactant is an anionic surfactant. 5. The aqueous adjuvant concentrate of claim 4 wherein the anionic surfactant is chosen among alkyl sulfosuccinic acids and anionic esters of alkylpolyglycosides. 6. The aqueous adjuvant concentrate of claim 1 wherein the hydroxypropyl tamarind gum has a hydroxypropyl molar substitution of from about 0.1 to about 2.5. 7. The aqueous adjuvant concentrate of claim 6 wherein the hydroxypropyl tamarind gum has a hydroxypropyl molar substitution of from about 0.2 to about 1.0.
having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system · CPC title
containing ingredients stabilising the active ingredients · CPC title
containing acyclic or cycloaliphatic radicals · CPC title
Aryloxy-carboxylic acids; Derivatives thereof · CPC title
having at least one oxygen or sulfur atom attached to an aromatic ring system · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.